Experience:
No experience
Employment Type:
Full time
Posted:
1/4/2016
Job Category:
Software Development
Software Engineer - Big Data Research Platform
(This job is no longer available)
23andMe, Inc. | Mountain View, CA
loading
loading
School
Major
Grad Date
 
 

Not sure what types of jobs you are interested in?


Explore Jobs
Based on Your Education

Follow This Company
Share

Job Description

Outstanding software engineers of all levels of experience wanted! Solve cool and challenging engineering problems implementing a large scale data store, building data processing pipelines in the cloud, and powering novel research and analytical capabilities.
Work within a collaborative environment of small fast-paced development teams that have a mix of veteran engineers and recent graduates. Come join us in our mission to be the world's trusted source of personal genetic information.
Responsibilities
Design and implement new infrastructure, features, and frameworks Build data analysis pipelines for statistical phasing, imputation, & association analyses Participate in product development process Write unit and functional tests Solve performance and scalability problems Requirements
B.S. in Computer Science or a related field Working knowledge of Python and/or Java Experience engineering high volume data pipelines and scientific workflows Experience working with cloud platforms such as AWS, Google Cloud Platform, etc. Experience with distributed computing and large scale data processing Experience solving problems with Hadoop and related technologies (HDFS, MapReduce, HBase, Spark, etc.) Interest in bioinformatics Thrive with minimum supervision to deliver well-designed high-quality code on time About Us
23andMe is the leading personal genetics company. We are dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. Our mission is to personalize health care by making and supporting meaningful discoveries through genetic research. Combining web development, computer science, genetics, social media, and informatics, 23andMe is at the forefront of a new era in personal genetics.

About 23andMe, Inc.

We support the Subcommittee and FDA in the effort to create an improved regulatory framework for genetic testing. We are already working with FDA, NIH, and other organizations to strengthen regulations for all laboratory testing, including genetic testing. Indeed, we first met with the FDA in 2007, before we ever offered our service to consumers. Thereafter, in 2008, we met with FDA Commissioner von Eschenbach and his staff, and they encouraged us to proceed. We have had ongoing discussions with FDA since that time. Tomorrow, we will present our regulatory proposal to the FDA. Our plan takes into account rapid technological innovation and ensures the analytical and clinical validity of all laboratory tests. In addition, we think new regulations should provide transparency across the industry so that consumers know what they are getting from the services they choose. At the heart of any new regulations should be the requirement that DTC genetic companies operate at the highest levels of science and ethics. 23andMe grounds its service in several core elements: informed consent and strong privacy protections; educating customers about personal considerations they should take into account when using our service; educating customers and providing full transparency about the science behind our service; and recommending that, if customers have questions about their results, they should coordinate with their physicians or a genetic counselor. Indeed, we are proud that, in 2008, our company's DNA-testing service was selected by TIME Magazine as the number one "Invention of the Year." One of 23andMe's core missions is the development of innovative solutions for accelerating genetic research. Our database is one of the largest collections of genetic and health information in existence, and has already led to published discoveries. We are currently working with the Parkinson's Institute on research aimed at discovering the genetic factors underlying Parkinson's disease. We are proud to have with us today the head of the Parkinson's Institute, Dr. William Langston, one of the leading Parkinson's researchers in America. We appreciate the concerns that people who receive DTC genetic information could make harmful decisions without consulting a physician, or could be lulled into inaction based on their results. However, we have seen neither data nor scientific literature to support this view. Indeed, the current scientific literature, combined with our own experience, shows that people do not take rash or unconsidered actions. Moreover, 23andMe's service is consistent with the FDA's long history of approving at-home, over-the-counter laboratory tests for HIV, hepatitis, and other diseases, in addition to permitting consumers direct access to tests for other conditions, such as high cholesterol and pregnancy. We believe the current regulatory landscape is ready for improvement, and we welcome your interest and leadership in this area. Thank you, and I look forward to your questions.